Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre study.

IF 8.6 1区 医学 Q1 SURGERY
Charlotte L van Veldhuisen, Charlotte A Leseman, Fleur E M De Rijk, Joana Marques-Antunes, Fabio Ausania, Orlin Belyaev, Frederik Berrevoet, Marja A Boermeester, Ugo Boggi, Stefan A Bouwense, Marco J Bruno, Olivier R Busch, Kevin C Conlon, Safi Dokmak, Massimo Falconi, Poya Ghorbani, Filip Gryspeerdt, Roel Haen, Arturan Ibrahimli, Jakob R Izbicki, Christina Krikke, Arto Kokkola, Lancelot Marique, J Sven D Mieog, Gennaro Nappo, Janis Pavulans, Haralds Plaudis, Geert Roeyen, Pasquale Scognamiglio, Domenico Tamburrino, Tore Tholfsen, Marie Toschka, Faik G Uzunoglu, Susan van Dieren, Casper H J Van Eijck, Jeanin E van Hooft, Hjalmar C van Santvoort, Robert C Verdonk, Rogier P Voermans, Anne Waage, Marc G Besselink
{"title":"Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre study.","authors":"Charlotte L van Veldhuisen, Charlotte A Leseman, Fleur E M De Rijk, Joana Marques-Antunes, Fabio Ausania, Orlin Belyaev, Frederik Berrevoet, Marja A Boermeester, Ugo Boggi, Stefan A Bouwense, Marco J Bruno, Olivier R Busch, Kevin C Conlon, Safi Dokmak, Massimo Falconi, Poya Ghorbani, Filip Gryspeerdt, Roel Haen, Arturan Ibrahimli, Jakob R Izbicki, Christina Krikke, Arto Kokkola, Lancelot Marique, J Sven D Mieog, Gennaro Nappo, Janis Pavulans, Haralds Plaudis, Geert Roeyen, Pasquale Scognamiglio, Domenico Tamburrino, Tore Tholfsen, Marie Toschka, Faik G Uzunoglu, Susan van Dieren, Casper H J Van Eijck, Jeanin E van Hooft, Hjalmar C van Santvoort, Robert C Verdonk, Rogier P Voermans, Anne Waage, Marc G Besselink","doi":"10.1093/bjs/znaf068","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Randomized trials have demonstrated the superiority of surgery over endoscopy in patients with symptomatic chronic pancreatitis. However, large international studies quantifying the impact of surgery on chronic pancreatitis are lacking. The aim of this study was to evaluate current practice across Europe regarding indications, surgical techniques, and outcomes of surgery for chronic pancreatitis.</p><p><strong>Methods: </strong>A prospective multicentre study of consecutive patients undergoing surgery for symptomatic chronic pancreatitis from 22 centres in 13 countries from 1 June 2021 to 30 November 2022 was conducted. The outcome of interest in patients with pain as an indication was the Izbicki pain score at 6-month follow-up, with complete pain relief defined as an Izbicki pain score ≤10 and partial pain relief defined as an Izbicki pain score >10, but with a >50% decrease compared with the baseline score. Quality of life was assessed using Pancreatitis Quality of Life Instrument (PANQOLI) and 12-Item Short-Form (SF-12) surveys. Predictors of pain relief were analysed using multivariable analysis.</p><p><strong>Results: </strong>Overall, 207 patients underwent surgery (24.6% underwent surgical drainage procedures, 29.5% underwent duodenum-preserving head resections, and 45.9% underwent formal pancreatic resections). Before surgery, 48.8% used opioids and 51.2% had undergone prior endoscopic treatment. Major morbidity occurred in 14.0% and the 90-day mortality rate was 1.4%. Among 113 patients operated on for pain, the median Izbicki pain score decreased from 61.3 to 19.0 at 6 months (P < 0.001). Pain relief was achieved in 72.6% (43 patients reported complete pain relief and 39 patients reported partial pain relief). PANQOLI and SF-12 Physical Component Summary scores improved significantly (P < 0.001). Longer symptom duration (OR 0.95 (95% c.i. 0.90 to 1.00), P = 0.045) and use of opioids before surgery (OR 3.16 (95% c.i. 1.04 to 9.64), P = 0.043) predicted less pain relief.</p><p><strong>Conclusion: </strong>Surgery for chronic pancreatitis across Europe was performed with low morbidity. Patients reported good pain relief and improvements in quality-of-life scores. Multidisciplinary consultation is recommended for all patients with chronic pancreatitis before undergoing any intervention.</p>","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038157/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bjs/znaf068","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Randomized trials have demonstrated the superiority of surgery over endoscopy in patients with symptomatic chronic pancreatitis. However, large international studies quantifying the impact of surgery on chronic pancreatitis are lacking. The aim of this study was to evaluate current practice across Europe regarding indications, surgical techniques, and outcomes of surgery for chronic pancreatitis.

Methods: A prospective multicentre study of consecutive patients undergoing surgery for symptomatic chronic pancreatitis from 22 centres in 13 countries from 1 June 2021 to 30 November 2022 was conducted. The outcome of interest in patients with pain as an indication was the Izbicki pain score at 6-month follow-up, with complete pain relief defined as an Izbicki pain score ≤10 and partial pain relief defined as an Izbicki pain score >10, but with a >50% decrease compared with the baseline score. Quality of life was assessed using Pancreatitis Quality of Life Instrument (PANQOLI) and 12-Item Short-Form (SF-12) surveys. Predictors of pain relief were analysed using multivariable analysis.

Results: Overall, 207 patients underwent surgery (24.6% underwent surgical drainage procedures, 29.5% underwent duodenum-preserving head resections, and 45.9% underwent formal pancreatic resections). Before surgery, 48.8% used opioids and 51.2% had undergone prior endoscopic treatment. Major morbidity occurred in 14.0% and the 90-day mortality rate was 1.4%. Among 113 patients operated on for pain, the median Izbicki pain score decreased from 61.3 to 19.0 at 6 months (P < 0.001). Pain relief was achieved in 72.6% (43 patients reported complete pain relief and 39 patients reported partial pain relief). PANQOLI and SF-12 Physical Component Summary scores improved significantly (P < 0.001). Longer symptom duration (OR 0.95 (95% c.i. 0.90 to 1.00), P = 0.045) and use of opioids before surgery (OR 3.16 (95% c.i. 1.04 to 9.64), P = 0.043) predicted less pain relief.

Conclusion: Surgery for chronic pancreatitis across Europe was performed with low morbidity. Patients reported good pain relief and improvements in quality-of-life scores. Multidisciplinary consultation is recommended for all patients with chronic pancreatitis before undergoing any intervention.

欧洲慢性胰腺炎手术治疗(ESCOPA):前瞻性多中心研究。
背景:随机试验表明,在症状性慢性胰腺炎患者中,手术优于内窥镜检查。然而,量化手术对慢性胰腺炎影响的大型国际研究缺乏。本研究的目的是评估欧洲目前关于慢性胰腺炎的适应症、手术技术和手术结果的实践。方法:在2021年6月1日至2022年11月30日期间,对13个国家22个中心接受症状性慢性胰腺炎手术的连续患者进行了一项前瞻性多中心研究。以疼痛为适应症的患者感兴趣的结果是6个月随访时的Izbicki疼痛评分,完全疼痛缓解定义为Izbicki疼痛评分≤10,部分疼痛缓解定义为Izbicki疼痛评分>0,但与基线评分相比>下降50%。采用胰腺炎生活质量量表(PANQOLI)和12项问卷调查表(SF-12)评估患者的生活质量。采用多变量分析对疼痛缓解的预测因素进行分析。结果:总的来说,207例患者接受了手术(24.6%的患者接受了手术引流,29.5%的患者接受了保留十二指肠的头部切除术,45.9%的患者接受了正式的胰腺切除术)。术前48.8%的患者使用过阿片类药物,51.2%的患者之前接受过内窥镜治疗。主要发病率为14.0%,90天死亡率为1.4%。在113例因疼痛而手术的患者中,6个月时Izbicki疼痛评分中位数由61.3降至19.0 (P < 0.001)。72.6%的患者实现了疼痛缓解(43例患者报告完全疼痛缓解,39例患者报告部分疼痛缓解)。PANQOLI和SF-12 Physical Component Summary得分显著提高(P < 0.001)。较长的症状持续时间(OR 0.95 (95% ci . 0.90 ~ 1.00), P = 0.045)和术前使用阿片类药物(OR 3.16 (95% ci . 1.04 ~ 9.64), P = 0.043)预示疼痛缓解较少。结论:手术治疗慢性胰腺炎在欧洲的发病率很低。患者报告了良好的疼痛缓解和生活质量评分的改善。建议所有慢性胰腺炎患者在接受任何干预之前进行多学科咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.70
自引率
7.30%
发文量
1102
审稿时长
1.5 months
期刊介绍: The British Journal of Surgery (BJS), incorporating the European Journal of Surgery, stands as Europe's leading peer-reviewed surgical journal. It serves as an invaluable platform for presenting high-quality clinical and laboratory-based research across a wide range of surgical topics. In addition to providing a comprehensive coverage of traditional surgical practices, BJS also showcases emerging areas in the field, such as minimally invasive therapy and interventional radiology. While the journal appeals to general surgeons, it also holds relevance for specialty surgeons and professionals working in closely related fields. By presenting cutting-edge research and advancements, BJS aims to revolutionize the way surgical knowledge is shared and contribute to the ongoing progress of the surgical community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信